Welcome to our dedicated page for Conmed news (Ticker: CNMD), a resource for investors and traders seeking the latest updates and insights on Conmed stock.
CONMED Corporation (NASDAQ: CNMD) news coverage tracks developments from this medical device manufacturer serving orthopedic surgeons, general surgeons, and other surgical specialists worldwide. The company produces surgical instruments, powered equipment, and patient monitoring devices used in operating rooms and ambulatory surgery centers.
CONMED news typically includes quarterly and annual earnings reports detailing revenue performance across its orthopedic and general surgery product lines. The company reports results that break down performance by geographic region and product category, providing insight into procedure volume trends and market share dynamics in the competitive medical device sector.
Beyond financial performance, CONMED announcements cover product launches and FDA clearances for new surgical devices, strategic decisions regarding product portfolio focus, and changes to the company's board of directors and executive leadership. The company also announces quarterly dividend declarations, reflecting its approach to returning capital to shareholders.
Medical device companies like CONMED operate in a regulated environment where new product introductions require extensive clinical validation and regulatory approval. News regarding the company's product development pipeline and regulatory submissions can signal future revenue opportunities. Additionally, announcements about manufacturing operations, acquisitions, and divestitures provide context for understanding the company's strategic direction within the surgical device market.
CONMED Corporation (NYSE: CNMD) announced participation in a virtual fireside chat at the KeyBanc Life Sciences & MedTech Investor Forum on March 23, 2021, at 11:30 a.m. ET. The session will feature Chair and CEO Curt R. Hartman and CFO Todd W. Garner. Investors can access the live webcast via the Company’s website at www.conmed.com, which will be available for replay post-event. CONMED specializes in minimally invasive surgical devices used across various medical specialties.
CONMED Corporation (NYSE: CNMD) has announced a quarterly cash dividend of $0.20 per share, payable on April 5, 2021 to shareholders on record as of March 15, 2021.
CONMED is a medical technology company that provides surgical devices for minimally invasive procedures, serving various specialties including orthopedics and neurosurgery. The announcement reflects the company's ongoing commitment to returning value to shareholders.
CONMED Corporation (NYSE: CNMD) announced participation of Curt R. Hartman, Chair of the Board and CEO, alongside Todd W. Garner, CFO, in a virtual fireside chat at the 10th Annual SVB Leerink Global Healthcare Conference. The event is scheduled for 9:20 a.m. ET on February 25, 2021.
The live webcast will be available in the ‘Investors’ section of their website, and a replay will be accessible post-event. CONMED is a provider of surgical devices for minimally invasive procedures across various specialties, including orthopedics and neurosurgery.
CONMED Corporation (NYSE: CNMD) reported Q4 2020 sales of $252.8 million, down 4.5% year-over-year, with domestic revenue decreasing 0.7% and international revenue falling 9.1%. Diluted EPS rose to $0.81 from $0.49 in Q4 2019, while adjusted EPS decreased from $0.90 to $0.84. For the full year, sales were $862.5 million, a 9.7% decline, and diluted EPS was $0.32 versus $0.97 in 2019. The company expects 2021 revenue between $975 million and $1.02 billion, with adjusted EPS forecasted at $2.85 to $3.05.
CONMED Corporation (CNMD) will report its fourth quarter and full year 2020 financial results on January 27, 2021, post-market close. A conference call hosted by management will take place at 4:30 p.m. ET to discuss these results. Participants can join the call by dialing specific numbers provided or via a webcast accessible through the company’s website. A recording of the call will be available for one week following the event. The company specializes in surgical devices for minimally invasive procedures across various medical specialties.
CONMED Corporation (NYSE: CNMD) announces that Curt R. Hartman and Todd W. Garner will present at the 39th Annual J.P. Morgan Virtual Healthcare Conference on January 11, 2021, at 10:00 a.m. ET. The presentation will be accessible via a live webcast on the Company's website at www.conmed.com, with a replay available post-event. CONMED specializes in medical technology, providing surgical devices for minimally invasive procedures across various specialties, including orthopedics and neurosurgery.
CONMED Corporation (NYSE: CNMD) announced participation in the Piper Sandler 32nd Annual Virtual Healthcare Conference. CEO Curt R. Hartman and CFO Todd W. Garner will feature in a pre-recorded fireside chat, available from 10:00 a.m. ET on November 23 until December 3, 2020. Interested parties can access the chat through the conference site or via the Company’s website. CONMED specializes in surgical devices for minimally invasive procedures across various specialties including orthopedics and neurosurgery.
CONMED Corporation (NYSE: CNMD) has declared a quarterly cash dividend of $0.20 per share, scheduled for payment on January 5, 2021, to shareholders of record as of December 15, 2020. This dividend reflects the company's commitment to returning value to its shareholders. As a medical technology company, CONMED offers surgical devices for various medical specialties including orthopedics, general surgery, and more. The announcement signals confidence in the company's ongoing financial health and operational stability.
CONMED Corporation (NYSE: CNMD) announced a change in its presentation time at the Jefferies Virtual London Healthcare Conference to 11:25 a.m. ET on November 18, 2020. Todd W. Garner, Executive Vice President and CFO, will represent the company. The presentation will be available via a live webcast on the company's website, with a replay accessible afterward.
CONMED specializes in medical technology, providing surgical devices for minimally invasive procedures across various specialties, including orthopedics, general surgery, and more. For further details, visit www.conmed.com.
CONMED Corporation (NYSE: CNMD) announced that Todd W. Garner, Executive Vice President and CFO, will present at the Jefferies Virtual London Healthcare Conference on November 18, 2020, at 12:25 p.m. ET. A live webcast of the presentation will be available in the ‘Investors’ section on the company’s website, with a replay accessible post-event. CONMED specializes in medical technology, providing surgical devices for minimally invasive procedures across various specialties including orthopedics and neurosurgery. For further details, visit www.conmed.com.
FAQ
What is the current stock price of Conmed (CNMD)?
What is the market cap of Conmed (CNMD)?
